SWIFTWATER, Pa. – Sanofi Pasteur, the vaccine division of Sanofi has shipped the first of its nearly 70 million flu vaccine doses to health care providers for the upcoming flu season. This year’s supply uses both egg-based and recombinant technologies, and includes increased production of Flublok Quadrivalent vaccine and Fluzone High-Dose vaccine, as well as continued
SWIFTWATER, Pa. — Sanofi Pasteur is shipping its first doses of Fluzone vaccines for the 2016-17 flu season following their release by the Food and Drug Administration. Sanofi’s vaccines division said the shipment marks the start of more than 65 million doses of seasonal flu shots that it will deliver to U.S. health care providers
TORONTO — Health Canada has approved Sanofi Pasteur’s Fluzone High-Dose influenza vaccine developed for adults age 65 and older. A trivalent vaccine, Fluzone High-Dose contains four times the amount of hemagglutinin (HA) per strain versus a standard dose vaccine and is administered as a single, 0.5 ml intramuscular injection. The higher-dose flu shot, which already has
